[Results of radiotherapy in 22 patients with epidemic Kaposi's sarcoma]. 1990

R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
Istituto di Clinica Dermatologia I, Università di Milano.

Radiotherapy is a first choice treatment of skin and oral cavity lesions of epidemic Kaposi sarcoma. It has cosmetic aims in the early stages of the disease, and palliative ones to reduce soreness and associated oedema in the lesions of a more advanced disease. This treatment modality has few side effects and does not modify the immunological condition of the patients. These statements, as they result from the review of the related literature, are here assessed by the experience of the Authors in a series of 22 patients, treated by means of orthovoltage radiotherapy, which allows intracavitary treatments (contact X-ray therapy) and small-sized irradiation fields.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
December 1994, International journal of radiation oncology, biology, physics,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
June 1987, Seminars in oncology,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
November 1991, International journal of radiation oncology, biology, physics,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
November 1990, Clinical oncology (Royal College of Radiologists (Great Britain)),
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
June 1990, Seminars in oncology,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
April 1991, Medicina clinica,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
September 1998, Oncology (Williston Park, N.Y.),
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
December 1989, AIDS (London, England),
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
January 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
R Piccinno, and M Caccialanza, and M Cusini, and P Cagliani, and L Mainardi
August 1984, JAMA,
Copied contents to your clipboard!